Association of the IgG response to Plasmodium falciparum merozoite protein (C-terminal 19 kD) with clinical immunity to malaria in the Brazilian Amazon region

American Journal of Tropical Medicine and Hygiene

Volumn 66, Issue 5, 2002, Pages 461-466

  Braga, Érika Martins ^a   Barros, Rosa Maria ^a   Reis, Tânia Afonso ^a   Fontes, Cor Jesus F ^a   Morais, Cristiane Guimarães ^a   Martins, Maria Sônia ^a   Krettli, Antoniana Ursine ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; MEROZOITE SURFACE PROTEIN 1;

ADULT; ANTIBODY RESPONSE; ARTICLE; BRAZIL; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE TRANSMISSION; FEMALE; HUMAN; IMMUNE RESPONSE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MEROZOITE; PARASITE PREVALENCE; PARASITEMIA; PLASMODIUM FALCIPARUM;

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0036560269     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2002.66.461     Document Type: Article

References (39)

1. Preventing merozoite invasion of erythrocytes
2. A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies
3. Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19 kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1
4. A longitudinal investigation of IgG and IgM antibody response to the merozoite surface protein-1 19-kilodalton domain of Plasmodium falciparum in pregnant women and infants: Associations with febrile illness, parasitemia, and anemia
5. Proteolytic processing of the Plasmodium falciparum merozoite surface protein-1 produces a membrane-bound fragment containing two epidermal growth factor-like domains
6. Malaria parasites and erythrocyte invasion
7. Antibodies against merozoite surface protein (MSP)-1 (19) are a major component of the invasion inhibitory response in individuals immune to malaria
8. Gamma-globulin and acquired immunity to human malaria
9. The passive transfer of human malaria immunity
10. Parasitological and clinical human response to immunoglobulin administration in falciparum malaria
11. Peripheral blood mononuclear cells in the squirrel monkey Saimiri sciureus: Characterization and functional aspects of T lymphocytes
12. Manipulating blood T cells and B cells from squirrel monkeys: Some technical considerations
13. Epidemiological correlation between levels of antibodies promoting merozoites phagocytosis of Plasmodium falciparum and malaria-immune status
14. Effector cells involved in nonspecific and antibody-dependent mechanisms direct against Plasmodium falciparum blood stages in vitro
15. Mechanisms of defense against P. falciparum asexual blood stages in humans
16. Towards a vaccine against asexual blood stage infection by Plasmodium falciparum
17. Unstable hypoendemic malaria in Rondonia (western Amazon Region, Brazil): Epidemic outbreaks and work-associated incidence in an agro-industrial rural settlement
18. Hypoendemic malaria in Rondonia (Brazil, western Amazon region): Seasonal variation and risk groups in an urban locality
19. Dados epidemiológicos de malária em todo o Brasil, referentes a 1993
20. Epidemiology of malaria
21. Expression and antigenicity of Plasmodium falciparum major merozoite surface protein (MSP1-19) variants secreted from Saccharomyces cerevisiae
22. Persistence of humoral but not cellular responses against sporozoite and blood-stage malaria antigens after seven years after a brief exposure to Plasmodium vivax
23. The isotype composition and avidity of naturally acquired anti-Plasmodium falciparum antibodies: Differential patterns in clinically immune Africans and Amazonian patients
24. Defense mechanisms and immune evasion in the interplay between the human immune system and Plasmodium falciparum
25. Host-parasite interaction and morbidity in malaria endemic areas
26. Allelic diversity and antibody recognition of Plasmodium falciparum merozoite surface protein-1 during hypoendemic malaria transmission in the Brazilian Amazon region
27. Analysis of the sequence diversity in the Plasmodium falciparum merozoite surface protein-1
28. Sequence heterogeneity of the C- terminal, Cys-rich region of the merozoite surface protein-1 (MSP-1) in field samples Plasmodium falciparum
29. Sequence diversity and linkage disequilibrium within the merozoite surface protein-1 (MSP-1) locus of Plasmodium falciparum: A longitudinal study in Brazil
30. Infrequency of asymptomatic malaria in an endemic area in Amazonas, Brazil
31. High prevalence of asymptomatic malaria in gold mining areas in Brazil
32. Symptomless Plasmodium vivax infections in native Amazonians
33. Serum antibodies from malaria-exposed people recognize conserved epitopes formed by the two epidermal growth factor motifs of MSP1(19), the carboxy-terminal fragment of the major merozoite surface protein of Plasmodium falciparum
34. Natural immune response to the C-terminal 19-kilodalton domain of P. falciparum merozoite surface protein 1
35. Differential patterns of human immunoglobulin G subclass responses to distinct regions of a single protein, the merozoite surface protein 1 of Plasmodium falciparum
36. Anti-merozoite surface protein-1 19-kDa IgG in mother-infant pairs naturally exposed to Plasmodium falciparum: Subclass analysis with age, exposure to asexual parasitemia, and protection against malaria. V
37. Age-specific prevalence of Plamodium falciparum among six population with limited histories of exposure to endemic malaria
38. Age-dependent characteristics of protection v. susceptibility to Plasmodium falciparum
39. Immunity to non-cerebral severe malaria is acquired after one or two infections